Cocrystal Pharma, Inc. (COCP) — 分析师展望 / 分析师共识目标价为. 基于 1 位分析师评级, 共识为 看涨 — 1 买入.
分析师预估 每股收益(EPS)为 $-1.93 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.72 vs 预期 $-1.93 (超预期 +10.9%). 2025: 实际 $-0.78 vs 预期 $-0.80 (超预期 +1.9%). 分析师准确度: 93%.
COCP 分析师评级
Buy
基于过去3个月内 1 位分析师对 Cocrystal Pharma, Inc. 的评级
EPS 预测 — COCP
93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.72
vs Est –$1.93
▲ 12.2% off
2025
Actual –$0.78
vs Est –$0.80
▲ 1.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — COCP
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
